Novartis Zelmac Well Tolerated In Alternating IBS, Study Suggests

Novartis' constipation-predominant irritable bowel syndrome therapy Zelmac is well tolerated in patients with alternating IBS, data presented at the United European Gastroenterology Week in Brussels Nov. 28 suggests.